Forbes: "The 100 Leading Pioneers Of AI Drug Development" (Pierre Baldi named)

The profile of these people is quite interesting as 43% of them come from Academia. It seems that some of the big brains of the planet have targeted their efforts on improving human life and possibly extending the lifespan. The impact of AI leaders in this category is characterized by a high number of peer-reviewed publications, a high level of citation, pioneering roles in theoretical or engineering of ML/AI for drug discovery, a notable theoretical breakthrough, a technical invention, or a widely adopted commercial model.

Read the full story at Forbes.